Literature DB >> 29709755

The Outcomes of Pituitary Apoplexy with Conservative Treatment: Experiences at a Single Institution.

Youngbeom Seo1, Yong Hwy Kim2, Yun-Sik Dho3, Jung Hee Kim4, Jin Wook Kim3, Chul-Kee Park3, Dong Gyu Kim3.   

Abstract

OBJECTIVE: Pituitary apoplexy is an unpredictable complication caused by hemorrhage or infarction in a pituitary adenoma. We retrospectively analyzed the radiologic and clinical outcomes of patients with conservatively managed pituitary apoplexy.
METHODS: A total of 32 patients who had undergone conservative treatment with high-dose corticosteroid replacement were enrolled in this study. This cohort study consisted of 20 male and 12 female patients. The median patient age was 60 years. Five patients had a previously diagnosed pituitary tumor, and one third of the patients had a history of hypertension.
RESULTS: The median follow-up duration was 50 months. The median tumor volumes at the initial and final assessments were 2.75 cm3 (range, 0.32-10.7 cm3) and 0.64 cm3 (range, 0-8.74 cm3), respectively. Complete radiographic regression occurred in 9 of the 32 patients, partial regression occurred in 14 patients, and no change in size or progression occurred in 9 patients. Eighteen of the 32 patients had visual disturbances at the initial presentation; in this subgroup, 17 patients showed improvement over the course of the study. One patient had newly developed diplopia related to tumor progression. Nineteen of the 32 patients had ≥1 hormonal deficiency at the initial assessment, 8 of whom recovered to normal endocrine status. Three patients developed a new hormonal deficiency during the follow-up, and 3 patients experienced tumor recurrence.
CONCLUSIONS: This study showed the regression of tumors related to pituitary apoplexy, with favorable ophthalmologic and endocrinologic recovery. Conservative management should be considered in patients without severe or progressive neuro-ophthalmic deficits.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conservative treatment; Long-term recurrence; Pituitary adenoma; Pituitary apoplexy

Mesh:

Year:  2018        PMID: 29709755     DOI: 10.1016/j.wneu.2018.04.139

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Visual and Hormone Outcomes in Pituitary Apoplexy: Results of a Single Surgeon, Single Institution 15-Year Retrospective Review and Pooled Data Analysis.

Authors:  Scott C Seaman; Mark C Dougherty; Mario Zanaty; Leslie A Bruch; Scott M Graham; Jeremy D W Greenlee
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

2.  Pituitary Apoplexy: A Retrospective Study of 33 Cases From a Single Center.

Authors:  Henrik Falhammar; Sofia Tornvall; Charlotte Höybye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-15       Impact factor: 5.555

Review 3.  Revisiting Pituitary Apoplexy.

Authors:  Diane Donegan; Dana Erickson
Journal:  J Endocr Soc       Date:  2022-07-26

4.  Pituitary apoplexy presenting as isolated third cranial nerve palsy: case series.

Authors:  Ramesh Shrestha; Suresh Bishokarma; Sushil Rayamajhi; Sunita Shrestha; Saurav Lamichhane; Pratyush Shrestha; Suraj Thulung
Journal:  J Surg Case Rep       Date:  2022-08-23

5.  A Case of Nonapoplectic Pituitary Adenoma Presenting with Isolated Oculomotor Nerve Palsy.

Authors:  Kunio Yokoyama; Naokado Ikeda; Akira Sugie; Makoto Yamada; Hidekazu Tanaka; Yutaka Ito; Masahiro Kawanishi
Journal:  Asian J Neurosurg       Date:  2021-05-28

6.  Pituitary apoplexy associated with acute COVID-19 infection and pregnancy.

Authors:  Julie L Chan; Kimberly D Gregory; Sarah S Smithson; Mariam Naqvi; Adam N Mamelak
Journal:  Pituitary       Date:  2020-09-11       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.